Clinical trial
Biomarkers of Tumor Response in Hypofractionated Radiotherapy
NCT02854449 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of Tumor Response in Hypofractionated Radiotherapy
- Lead sponsor
- Peking University First Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- December 31, 2020
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.